[Pharmaco-cellular enzymology of the mechanism of action of stiripentol in cardiazol-induced epilepsy. II. Glucose metabolism].
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology* / Q000627:therapeutic use; D001921:Brain / Q000201:enzymology; D001923:Brain Chemistry / Q000187:drug effects*; D004148:Dioxolanes / Q000494:pharmacology* / Q000627:therapeutic use; D004734:Energy Metabolism / Q000187:drug effects*; D004827:Epilepsy / Q000139:chemically induced / Q000378:metabolism* / Q000517:prevention & control; D005260:Female; D005947:Glucose / Q000378:metabolism*; D005954:Glucosephosphate Dehydrogenase / Q000037:antagonists & inhibitors; D006003:Glycogen / Q000378:metabolism; D008297:Male; D010433:Pentylenetetrazole / Q000633:toxicity; D051381:Rats; D011919:Rats, Inbred Strains
D000927:Anticonvulsants; D004148:Dioxolanes; D006003:Glycogen; D005954:Glucosephosphate Dehydrogenase; D005947:Glucose; C021092:stiripentol; D010433:Pentylenetetrazole
Enzymologie pharmaco-cellulaire du mode d'action du Stiripentol au cours de l'épilepsie cardiazolique--II. Le métabolisme glucidique.